0002126245-26-000002.txt : 20260515 0002126245-26-000002.hdr.sgml : 20260515 20260515125720 ACCESSION NUMBER: 0002126245-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260515 DATE AS OF CHANGE: 20260515 EFFECTIVENESS DATE: 20260515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORLI Oncology Ventures II SPV, LLC CENTRAL INDEX KEY: 0002126245 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-584221 FILM NUMBER: 26985048 BUSINESS ADDRESS: STREET 1: 131 CONTINENTAL DRIVE STREET 2: SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 BUSINESS PHONE: 4342380920 MAIL ADDRESS: STREET 1: 131 CONTINENTAL DRIVE STREET 2: SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 D 1 primary_doc.xml X0708 D LIVE 0002126245 ORLI Oncology Ventures II SPV, LLC 2371 Commonwealth Park South Columbus OH OHIO 43209 4342380920 DELAWARE None Limited Liability Company true 2025 - ORLI Partners LLC 2371 Commonwealth Park South Columbus OH OHIO 43209 Promoter Manager Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.1 false 2026-03-05 false true false 0 368750 368750 0 false 0 19 0 0 0 None false ORLI Oncology Ventures II SPV, LLC /s/ Kirk Carson Kirk Carson Authorized Signatory 2026-02-12